Semagltutide, is from the class of drugs called Glucagon-like Peptide (GLP-1) and is considered a game changer for weight loss, control of glucose and insulin insensitivity and ultimately, decreased fat mass and improved body composition

Semaglutide can be administered alone or in combination with another peptide called BPC-157, also known as a healing and regenerative peptide adding to its effectiveness.
Semaglutide can also be prescribed with Vitamin B12.

Apart from weight loss and improved body composition, many metabolic issues such as pre-diabetes are resolved.

Semaglutide works by suppressing appetite, thus increasing insulin secretion, and helping clients successfully stay on their reduced-calorie diet as it induces satiety.

More than 50 percent of patients have lost 15 %of their body weight, and about 40 percent are losing 20 percent of their body weight.

Patients also reduced their HA1C under 7 and significantly improved glucose levels and insulin sensitivity.

Improvements also include up to a 4.9 cm reduction in waist circumference, reduction in systolic blood pressure and reduction in triglyceride levels.

The program includes monthly prescriptions of GLP-1 and thyroid and metabolic testing every 4 months.